Skip to main content

Advertisement

Log in

Etiology and outcome of crescentic glomerulonephritis

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To determine the etiology, course and predictors of outcome in children with crescentic glomerulonephritis (GN).

Study design

Retrospective, descriptive study. Setting: Pediatric Nephrology Clinic at a referral center in Northern India.

Methods: Clinic records of patients aged <18 year with crescentic GN diagnosed from 2001–2010 and followed at least 12-months were reviewed. Crescentic GN, defined as crescents in >-50% glomeruli, was classified based on immunofluorescence findings and serology. Risk factors for renal loss (chronic kidney disease stage 4–5) were determined

Results

Of 36 patients, (median age 10 yr) 17 had immune complex GN and 19 had pauci-immune crescentic GN. The etiologies of the former were lupus nephritis (n=4), postinfectious GN (3), and IgA nephropathy, Henoch Schonlein purpura and membranoproliferative GN type II (2 each). Three patients with pauci-immune GN showed antineutrophil cytoplasmic antibodies (ANCA). Rapidly progressive GN was present in 33 patients, and required dialysis in 12. At median 34 (19–72) months, 2 patients with immune complex GN and 8 with pauci-immune GN showed renal loss. Renal survival was 94.1% at 3 yr, and 75.3% at 8 yr in immune complex GN; in pauci-immune GN survival was 63.2% and 54.1%, respectively (P=0.054). Risk factors for renal loss were oliguria at presentation (hazards ratio, HR 10.50; P=0.037) and need for dialysis (HR 6.33; P=0.024); there was inverse association with proportion of normal glomeruli (HR 0.91; P=0.042).

Conclusions

Pauci-immune GN constitutes one-half of patients with crescentic GN at this center. Patients with pauci-immune GN, chiefly ANCA negative, show higher risk of disease progression. Renal loss is related to severity of initial presentation and extent of glomerular involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dewan D, Gulati S, Sharma RK, Prasad N, Jain M, Gupta A, et al. Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries. Pediatr Nephrol. 2008;23:389–394.

    Article  PubMed  Google Scholar 

  2. Jardim HM, Leake J, Risdon RA, Barratt TM, Dillon MJ. Crescentic glomerulonephritis in children. Pediatr Nephrol. 1992;6:231–235.

    Article  PubMed  CAS  Google Scholar 

  3. A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int. 1985;27:450–458.

    Google Scholar 

  4. Srivastava RN, Moudgil A, Bagga A, Vasudev AS, Bhuyan UN, Sunderam KR. Crescentic glomerulonephritis in children: a review of 43 cases. Am J Nephrol. 1992;12:155–161.

    Article  PubMed  CAS  Google Scholar 

  5. Tapaneya-Olarn W, Tapaneya-Olarn C, Boonpucknavig V, Boonpucknavig S. Rapidly progressive glomerulonephritis in Thai children. J Med Assoc Thai. 1992;75:32–37.

    PubMed  Google Scholar 

  6. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–1177.

    Article  PubMed  Google Scholar 

  7. Koyama A, Yamagata K, Makino H, Arimura Y, wada T, Nitta K, et al. Japan RPGN Registry Group. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633–650.

    Google Scholar 

  8. Alsaad K, Oudah N, Al Ameer A, Fakeeh K, Al Jomaih A, Al Sayyari A. Glomerulonephritis with crescents in children: etiology and predictors of renal outcome. ISRN Pediatr. 2011; doi:10.5402/2011/507298.

    Google Scholar 

  9. Gupta R, Singh L, Sharma A, Bagga A, Agarwal SK, Dinda AK. Crescentic glomerulonephritis: A clinical and histomorphological analysis of 46 cases. Ind J Pathol Microbiol. 2011;54:597–561.

    Article  Google Scholar 

  10. Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol. 2005;19:263–276.

    Article  PubMed  CAS  Google Scholar 

  11. Bagga A, Mantan M. Nephrotic syndrome. Indian J Med Res. 2005;122:13–28.

    PubMed  Google Scholar 

  12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576.

    Article  Google Scholar 

  13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277.

    Article  PubMed  CAS  Google Scholar 

  14. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65: 936–941.

    Article  PubMed  CAS  Google Scholar 

  15. Miller MN, Baumal R, Poucell S, Steele BT. Incidence and prognostic importance of glomerular crescents in renal diseases of childhood. Am J Nephrol. 1984;4:244–247.

    Article  PubMed  CAS  Google Scholar 

  16. López-Gómez JM, Rivera F; Spanish Registry of Glomerulonephritis. Renal biopsy findings in acute renal failure in the Cohort of patients in the Spanish registry of glomerulonephritis. Clin J Am Soc Nephrol. 2008;3: 674–681.

    Google Scholar 

  17. Lin W, Chen M, Cui Z, Zhao M-H. The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract. 2010;116:c65–c74.

    Article  PubMed  Google Scholar 

  18. Kanjanabuch T, Kittikowit W, Eiam-Ong S. An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol. 2009;5:259–269.

    Article  PubMed  Google Scholar 

  19. Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody-negative pauciimmune crescentic glomerulonephritis. J Am Soc Nephrol. 2007; 18:599–605.

    Article  PubMed  Google Scholar 

  20. Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, Guillevin L, et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005;20:1392–1399.

    Article  PubMed  Google Scholar 

  21. Minz RW, Chhabra S, Joshi K, Rani L, Sharma N, Sakhuja V, et al. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study. Indian J Pathol Microbiol. 2012;55:28–32.

    Article  PubMed  Google Scholar 

  22. Csernok E, Ahlquist D, Ullrich S, Gross WL. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener’s granulomatosis and microscopic polyangiitis. Rheumatology (Oxford). 2002;41:1313–1317.

    Article  CAS  Google Scholar 

  23. Bajema IM, Hagen EC, Hermans J, Noël LH, Waldherr R, Ferrario F, et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999;56:1751–1758.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arvind Bagga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinha, A., Puri, K., Hari, P. et al. Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr 50, 283–288 (2013). https://doi.org/10.1007/s13312-013-0095-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-013-0095-z

Key words

Navigation